列特莫维尔用于异性造血细胞移植后的先发性细胞巨乳病毒治疗
Raena Kaur1, Duncan Purtill1, Julian Cooney1
1Department of Haematology, Fiona Stanley Hospital and PathWest Laboratory Medicine WA, Murdoch, Australia.
概括
莱特莫维尔 (LTV) 在移植患者中有效控制了细胞巨乳病毒 (CMV) 病毒性病,显示了细胞衰竭的改善. 这表明LTV可能是一个可行的替代品valganciclovir用于CMV移植后预防性治疗.
科学领域:
- 血液学 血液学 血液学
- 病毒学 病毒学
- 移植医学 移植医学
背景情况:
- 细胞巨乳病毒 (CMV) 感染是异性造血细胞移植 (alloHCT) 后并发症的重要原因.
- 目前使用瓦尔甘西克洛维尔 (VGC) 的预防性治疗 (PET) 与不良的血液学影响有关,包括细胞衰竭.
研究的目的:
- 为了评估莱特莫维尔 (LTV) 在患有细胞衰竭的alloHCT患者中进行CMV预防性治疗的疗效和安全性.
- 为了比较LTV与VGC在控制CMV病毒病和管理血液毒性的表现.
主要方法:
- 分析了一组10名alloHCT患者的队列,这些患者在2018年至2021年期间因细胞衰竭而接受CMV PET的LTV.
- 六名患者在过渡到LTV之前先前接受了VGC.
- 评估的关键参数包括治疗时间,持续时间,CMV病毒载量和细胞衰竭的变化.
主要成果:
- 与VGC相比,LTV的启动时间较晚 (中位数为90天),初始CMV病毒载量较低 (2.9 log10 IU/mL),而VGC的启动时间较晚 (中位数为42天,3.7 log10 IU/mL).
- 这两种抗病毒药物表现出每周可比的病毒载量减少率 (LTV:0.17 log10 IU/mL/week;VGC:0.18 log10 IU/mL/week).
- 患者在LTV治疗期间表现出改善的细胞衰竭,在停止治疗后没有显著的CMV病毒病.
结论:
- 莱特莫维尔在控制CMV病毒血症方面表现出有效性,特别是在晚些时候启动时,以及与VGC相比,在alloHCT后的病毒载量较低时.
- LTV对细胞衰竭产生了有利影响,这表明其作为替代PET策略的潜力.
- 需要进一步调查LTV作为HCT配合后的前期PET剂.
更多相关视频
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
12.8K
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12.5K
相关概念视频
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
